Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Verena Berg"'
Autor:
Birgit M. Reipert, Christoph J. Hofbauer, Bagirath Gangadharan, Verena Berg, Elizabeth Donnachie, Shannon Meeks, Maria Elisa Mancuso, Joel Bowen, Deborah L. Brown
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 5, p 2080 (2023)
Hemophilia A is a rare congenital bleeding disorder caused by a deficiency of functionally active coagulation factor VIII (FVIII). Most patients with the severe form of the disease require FVIII replacement therapies, which are often associated with
Externí odkaz:
https://doaj.org/article/3a392b54583547e3899c2560eda638c1
Autor:
Dorit Lehmann, Sabine Unterthurner, Verena Berg, Karin Hock, Padmapriya Ponnuswamy, Mantas Malisauskas, Brian A. Crowe, Bekir Erguener, Christoph Bock, Greg Hather, Birgit M. Reipert, Ivan Bilic
Publikováno v:
ImmunoMedicine, Vol 1, Iss 2, Pp n/a-n/a (2021)
Abstract The balance of activating and inhibitory signals from the low affinity Fc gamma receptors modulates immune responses triggered by IgG antibody‐immune complexes. In homeostasis, this leads to antigen clearance, while in autoimmune diseases
Externí odkaz:
https://doaj.org/article/226f797ef5064991b1804e9d0932ca01
Autor:
Helmut Paul, Verena Berg, Bagirath Gangadharan, Joel Bowen, Petra LeBeau, Jan Blatný, Christoph Male, Vlad C. Radulescu, Rosa Diaz, Maria Elisa Mancuso, Deborah L. Brown, Birgit M. Reipert
Publikováno v:
Blood Advances. 7:1831-1848
Factor VIII (FVIII) inhibitor formation is a major clinical concern during replacement therapy in patients with hemophilia A. Immune tolerance induction (ITI) is the only therapeutic approach to attempt inhibitor eradication and establishment of long
Autor:
Heinrich Kovar, Antonio Llombart-Bosch, Ewa Snaar-Jagalska, Elizabeth R. Lawlor, Katia Scotlandi, Sandra J. Strauss, Verena Berg, Adrienne M. Flanagan, Piero Picci, Raphaela Schwentner, Oscar M. Tirado, Carlos Rodriguez-Galindo, Isidro Machado, Stephan Niedan, Max Kauer, Wietske van der Ent, Argyro Fourtouna, Dave N.T. Aryee, Jozef Ban
Supplementary Tables S1-S4. Identification of HEY1 regulated genes downstream of EWS-FLI1 silencing in Ewing sarcoma (S1); Combined immunohistochemical staining results for samples from patients with metastases at diagnosis on TMA1 and 2 according to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90be5e3526370537b88bb720aeeda30d
https://doi.org/10.1158/0008-5472.22404536
https://doi.org/10.1158/0008-5472.22404536
Autor:
Heinrich Kovar, Antonio Llombart-Bosch, Ewa Snaar-Jagalska, Elizabeth R. Lawlor, Katia Scotlandi, Sandra J. Strauss, Verena Berg, Adrienne M. Flanagan, Piero Picci, Raphaela Schwentner, Oscar M. Tirado, Carlos Rodriguez-Galindo, Isidro Machado, Stephan Niedan, Max Kauer, Wietske van der Ent, Argyro Fourtouna, Dave N.T. Aryee, Jozef Ban
Supplementary Figure Legends. Legend for Supplementary Figures S1-S5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a5568c8de84bfd370dd6ff0535221a
https://doi.org/10.1158/0008-5472.22404545
https://doi.org/10.1158/0008-5472.22404545
Autor:
Heinrich Kovar, Antonio Llombart-Bosch, Ewa Snaar-Jagalska, Elizabeth R. Lawlor, Katia Scotlandi, Sandra J. Strauss, Verena Berg, Adrienne M. Flanagan, Piero Picci, Raphaela Schwentner, Oscar M. Tirado, Carlos Rodriguez-Galindo, Isidro Machado, Stephan Niedan, Max Kauer, Wietske van der Ent, Argyro Fourtouna, Dave N.T. Aryee, Jozef Ban
Supplementary Figures S1-S5. MDM4 modulation by HEY1 occurs downstream of TP53 (S1); Modulation of SIRT1 and TP53 induction upon ectopic expression of Flag-tagged HEY1 in the B-cell malignancy cell lines "697" and NALM6, and in primary keratinocytes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29206ec484b8ddfc478456ffc0e0b3f4
https://doi.org/10.1158/0008-5472.22404542.v1
https://doi.org/10.1158/0008-5472.22404542.v1
Autor:
Judit Rejtő, Helmut Schweiger, Verena Berg, Christoph J. Hofbauer, Gerhard Schuster, Karl Zwiauer, Birgit M. Reipert, Cihan Ay, Clemens Feistritzer, Peter Allacher, Ingrid Pabinger
Publikováno v:
Blood Advances. 6:946-958
Previous studies identified nonneutralizing FVIII-specific antibodies in the circulation of severe and nonsevere hemophilia A (sHA and nsHA) patients without FVIII inhibitors and also in some healthy individuals. To gain a better understanding of the
Autor:
Amy D. Shapiro, B. Gangadharan, J. Bowen, Christoph Male, Helmut Schweiger, C. J. Hofbauer, Verena Berg, Elena Santagostino, Michael Recht, Margaret V. Ragni, Janice M. Staber, Deborah L Brown, Jenny Klintman, Shannon L. Meeks, Birgit M. Reipert, Karin Fijnvandraat, Hassan M. Yaish, Jan Blatny, Catherine E. McGuinn, Eric S. Mullins, Vlad C. Radulescu
Publikováno v:
Blood Adv
Blood advances, 4(22), 5785-5796. American Society of Hematology
Blood advances, 4(22), 5785-5796. American Society of Hematology
Preventing factor VIII (FVIII) inhibitors following replacement therapies with FVIII products in patients with hemophilia A remains an unmet medical need. Better understanding of the early events of evolving FVIII inhibitors is essential for risk ide
Autor:
Raif S. Geha, Janet Chou, Hannes Stockinger, Verena Berg, Maria Seyerl-Jiresch, Akihiro Yachie, Alexander Puck, Peter Steinberger, Gerhard J. Zlabinger, Hyeryun Choe, Sarojinidevi Künig, Madhura Modak, Markus Kraller, Brell Jennifer, Leopold Öhler, Johannes Stöckl
Publikováno v:
Communications Biology, Vol 3, Iss 1, Pp 1-13 (2020)
Communications Biology
Communications Biology
Iron is essential for living cells. Uptake of iron-loaded transferrin by the transferrin receptor 1 (CD71, TFR) is a major but not sufficient mechanism and an alternative iron-loaded ligand for CD71 has been assumed. Here, we demonstrate that CD71 ut
Autor:
Joseph E. McClellan, Sesselja Ómarsdóttir, Nivedita Roy, Verena Berger, Cecilia Michel, Fausto Berti
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 15 (2024)
The development of a biosimilar is based on comparative structural, physicochemical, functional and clinical assessments. The sum of these analyses encompasses the ‘totality of evidence’, which demonstrates no clinically meaningful differences be
Externí odkaz:
https://doaj.org/article/9345a240043548c98ca554204428df9d